KIA
TMO icon

KCM Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

KCM Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Sell
5,125
-95
-2% -$45.6K 0.08% 146
2026
Q1 		$2.57M Sell
5,220
-107
-2% -$58.1K 0.09% 140
2025
Q4 		$3.09M Sell
5,327
-685
-11% -$387K 0.1% 126
2025
Q3 		$2.92M Sell
6,012
-83
-1% -$38.6K 0.09% 134
2025
Q2 		$2.47M Sell
6,095
-106
-2% -$44.3K 0.08% 144
2025
Q1 		$3.09M Sell
6,201
-391
-6% -$212K 0.11% 122
2024
Q4 		$3.43M Sell
6,592
-3,265
-33% -$1.8M 0.12% 122
2024
Q3 		$6.1M Buy
9,857
+65
+0.7% +$38.5K 0.21% 90
2024
Q2 		$5.42M Sell
9,792
-495
-5% -$284K 0.19% 90
2024
Q1 		$5.98M Sell
10,287
-294
-3% -$165K 0.22% 86
2023
Q4 		$5.62M Sell
10,581
-313
-3% -$152K 0.22% 86
2023
Q3 		$5.51M Sell
10,894
-258
-2% -$137K 0.24% 87
2023
Q2 		$5.82M Sell
11,152
-178
-2% -$96.1K 0.23% 90
2023
Q1 		$6.53M Sell
11,330
-30
-0.3% -$16.9K 0.26% 87
2022
Q4 		$6.26M Buy
11,360
+202
+2% +$107K 0.27% 85
2022
Q3 		$5.66M Sell
11,158
-338
-3% -$189K 0.26% 88
2022
Q2 		$6.25M Sell
11,496
-291
-2% -$160K 0.27% 85
2022
Q1 		$6.96M Buy
11,787
+515
+5% +$296K 0.25% 87
2021
Q4 		$7.52M Buy
11,272
+707
+7% +$441K 0.26% 89
2021
Q3 		$6.04M Buy
10,565
+643
+6% +$353K 0.24% 89
2021
Q2 		$5M Sell
9,922
-826
-8% -$390K 0.2% 99
2021
Q1 		$4.91M Sell
10,748
-818
-7% -$390K 0.22% 95
2020
Q4 		$5.39M Buy
11,566
+114
+1% +$53.5K 0.26% 88
2020
Q3 		$5.06M Buy
11,452
+267
+2% +$110K 0.28% 77
2020
Q2 		$4.05M Buy
11,185
+7,758
+226% +$2.6M 0.23% 87
2020
Q1 		$972K Buy
3,427
+264
+8% +$83.2K 0.07% 163
2019
Q4 		$1.03M Buy
3,163
+199
+7% +$60.3K 0.06% 177
2019
Q3 		$863K Buy
2,964
+74
+3% +$21.2K 0.05% 186
2019
Q2 		$849K Sell
2,890
-148
-5% -$40.8K 0.05% 186
2019
Q1 		$832K Sell
3,038
-244
-7% -$60.7K 0.05% 183
2018
Q4 		$735K Sell
3,282
-871
-21% -$204K 0.05% 257
2018
Q3 		$1.01M Buy
4,153
+223
+6% +$51.3K 0.06% 238
2018
Q2 		$814K Hold
3,930
– – 0.05% 260
2018
Q1 		$811K Buy
3,930
+47
+1% +$9.87K 0.05% 281
2017
Q4 		$737K Buy
3,883
+869
+29% +$166K 0.04% 301
2017
Q3 		$570K Buy
3,014
+1,326
+79% +$240K 0.03% 333
2017
Q2 		$295K Sell
1,688
-23
-1% -$3.86K 0.02% 443
2017
Q1 		$263K Buy
1,711
+20
+1% +$3.06K 0.02% 467
2016
Q4 		$239K Hold
1,691
– – 0.02% 483
2016
Q3 		$269K Sell
1,691
-97
-5% -$14.9K 0.02% 464
2016
Q2 		$264K Hold
1,788
– – 0.02% 447
2016
Q1 		$253K Buy
1,788
+56
+3% +$7.5K 0.02% 452
2015
Q4 		$246K Hold
1,732
– – 0.02% 458
2015
Q3 		$212K Buy
1,732
+120
+7% +$15.6K 0.02% 490
2015
Q2 		$209K Sell
1,612
-548
-25% -$71.4K 0.02% 509
2015
Q1 		$290K Buy
2,160
+159
+8% +$20.5K 0.02% 432
2014
Q4 		$251K Sell
2,001
-49
-2% -$5.96K 0.02% 455
2014
Q3 		$250K Buy
2,050
+100
+5% +$12.2K 0.02% 446
2014
Q2 		$230K Buy
+1,950
New +$229K 0.02% 447

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

KCM Investment Advisors's TMO Position: Q2 2026 in Review

KCM Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q2 2026, selling an estimated $45.6K and leaving 5,125 shares worth $2.57M. The position accounts for 0.08% of the portfolio, ranked #146.

KCM Investment Advisors first reported a position in TMO in Q2 2014 and has held it in 49 quarters since. The position peaked at $7.52M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • KCM Investment Advisors held 5,125 shares of Thermo Fisher Scientific worth $2.57M as of Q2 2026.
  • KCM Investment Advisors sold 95 Thermo Fisher Scientific shares in Q2 2026, an estimated $45.6K.
  • Thermo Fisher Scientific made up 0.08% of KCM Investment Advisors's portfolio in Q2 2026, its #146 holding.
  • KCM Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 49 quarters since.
  • KCM Investment Advisors's Thermo Fisher Scientific position peaked at $7.52M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on KCM Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.